What is the address of C&N HOLDING?

The registered office of C&N HOLDING is located at Terloonststraat 22, 1910 Kampenhout.

Is C&N HOLDING still active?

Yes. According to the CBE (29 October 2026) C&N HOLDING is active, legal situation “Normale toestand”, started on 5 July 2004.

Is C&N HOLDING registered on Peppol?

Yes, C&N HOLDING is registered on the Peppol network with ID 0208:0866337880.

What is the enterprise number of C&N HOLDING?

The enterprise number of C&N HOLDING is BE0866337880.

When was C&N HOLDING founded?

C&N HOLDING was founded on 5 July 2004.

Who are the directors of C&N HOLDING?

According to the 2025 annual accounts, the directors of C&N HOLDING are: Ter Loonst BV, Arphius BV.

Is C&N HOLDING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 July 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did C&N HOLDING make in 2025?

C&N HOLDING posted a profit after taxes of € 2,108,621 in financial year 2025.

What is the revenue of C&N HOLDING?

As a small company, C&N HOLDING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 108,316.

How many employees does C&N HOLDING have?

According to the 2025 annual accounts, C&N HOLDING has 0 full-time equivalents (FTE).

C&N HOLDING (Private Limited) - Kampenhout - BE0866337880

Q: What does C&N HOLDING do?

C&N HOLDING is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 5 July 2004, 1 establishment.

Dossier C&N HOLDING, printed on 29 October 2026 from databakkes.be/en/0866337880/c-n-holding. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

C&N HOLDING from Kampenhout, company number BE0866337880, closed financial year 2025 with a result of € 2.1 million after tax. For that financial year C&N HOLDING recorded a gross margin of € 108,316 and equity of € 7.7 million. Compared with financial year 2024, the result moved from € 5.5 million to € 2.1 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 7.7 million

▲ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 2.1 million

▼ 61% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 88,213

▲ 175% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 8,235 paid out

0 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

€ 188,467

▼ 31% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 349

▼ 84% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 210,862

▼ 62% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 87,025 Gross margin 2022: € 87,025 First fiscal year in the series	€ 75,203 Gross margin 2023: € 75,203 ▼ 14% vs 2022 (€ 87,025) Unfavourable step	€ 128,981 Gross margin 2024: € 128,981 ▲ 72% vs 2023 (€ 75,203) Favourable step	€ 108,316 Gross margin 2025: € 108,316 ▼ 16% vs 2024 (€ 128,981) Unfavourable step	▼ 16%
Profit after taxes	€ 6,527 Profit after taxes 2022: € 6,527 First fiscal year in the series	€ -25,618 Profit after taxes 2023: € -25,618 ▼ € 32,145 vs 2022 (€ 6,527) Unfavourable step	€ 5,461,691 Profit after taxes 2024: € 5,461,691 ▲ € 5.5 million vs 2023 (€ -25,618) Favourable step	€ 2,108,621 Profit after taxes 2025: € 2,108,621 ▼ 61% vs 2024 (€ 5,461,691) Unfavourable step	▼ 61%
Equity	€ 599,851 Equity 2022: € 599,851 First fiscal year in the series	€ 574,233 Equity 2023: € 574,233 ▼ 4% vs 2022 (€ 599,851) Unfavourable step	€ 5,457,614 Equity 2024: € 5,457,614 ▲ € 4.9 million vs 2023 (€ 574,233) Favourable step	€ 7,687,291 Equity 2025: € 7,687,291 ▲ 41% vs 2024 (€ 5,457,614) Favourable step	▲ 41%
Total debts	€ 651,671 Total debts 2022: € 651,671 First fiscal year in the series	€ 565,745 Total debts 2023: € 565,745 ▼ 13% vs 2022 (€ 651,671) Favourable step	€ 2,351,174 Total debts 2024: € 2,351,174 ▲ € 1.8 million vs 2023 (€ 565,745) Unfavourable step	€ 3,293,403 Total debts 2025: € 3,293,403 ▲ 40% vs 2024 (€ 2,351,174) Unfavourable step	▲ 40%
Cash	€ 2,996 Cash 2022: € 2,996 First fiscal year in the series	€ 784 Cash 2023: € 784 ▼ 74% vs 2022 (€ 2,996) Unfavourable step	€ 32,098 Cash 2024: € 32,098 ▲ € 31,315 vs 2023 (€ 784) Favourable step	€ 88,213 Cash 2025: € 88,213 ▲ 175% vs 2024 (€ 32,098) Favourable step	▲ 175%
Land & buildings	€ 375,283 Land & buildings 2022: € 375,283 First fiscal year in the series	€ 308,338 Land & buildings 2023: € 308,338 ▼ 18% vs 2022 (€ 375,283) Unchanged	€ 241,393 Land & buildings 2024: € 241,393 ▼ 22% vs 2023 (€ 308,338) Unchanged	€ 174,784 Land & buildings 2025: € 174,784 ▼ 28% vs 2024 (€ 241,393) Unchanged	▼ 28%
Retained profit	€ 99,851 Retained profit 2022: € 99,851 First fiscal year in the series	€ 74,233 Retained profit 2023: € 74,233 ▼ 26% vs 2022 (€ 99,851) Unfavourable step	€ 5,447,614 Retained profit 2024: € 5,447,614 ▲ € 5.4 million vs 2023 (€ 74,233) Favourable step	€ 7,547,999 Retained profit 2025: € 7,547,999 ▲ 39% vs 2024 (€ 5,447,614) Favourable step	▲ 39%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 88,310 Dividend 2024: € 88,310 Unchanged (€ 0) Unchanged	€ 8,235 Dividend 2025: € 8,235 ▼ 91% vs 2024 (€ 88,310) Unchanged	▼ 91%
Bank debt	€ 427,295 Bank debt 2022: € 427,295 First fiscal year in the series	€ 351,670 Bank debt 2023: € 351,670 ▼ 18% vs 2022 (€ 427,295) Favourable step	€ 272,128 Bank debt 2024: € 272,128 ▼ 23% vs 2023 (€ 351,670) Favourable step	€ 188,467 Bank debt 2025: € 188,467 ▼ 31% vs 2024 (€ 272,128) Favourable step	▼ 31%
Balance sheet total	€ 1,251,522 Balance sheet total 2022: € 1,251,522 First fiscal year in the series	€ 1,139,978 Balance sheet total 2023: € 1,139,978 ▼ 9% vs 2022 (€ 1,251,522) Unchanged	€ 7,808,788 Balance sheet total 2024: € 7,808,788 ▲ € 6.7 million vs 2023 (€ 1,139,978) Unchanged	€ 10,980,694 Balance sheet total 2025: € 10,980,694 ▲ 41% vs 2024 (€ 7,808,788) Unchanged	▲ 41%

Key figures of C&N HOLDING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to C&N HOLDING?

What happened at C&N HOLDING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 2.1 million (▼ 61% vs 2024). filed late Source: NBB ↗
Jul 14, 2004 New establishment in Kampenhout. KBO
Jul 5, 2004 Start of the company according to the CBE. KBO

In short

From € 6,527 profit in 2022 to € 2.1 million profit in 2025.

Paid € 754,800 in corporate taxes since 2022.

Best year ever: 2024, with € 5.5 million profit.

Paid out € 96,545 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Ter Loonst BV

Arphius BV

C&N HOLDING

Phytomed SA 51%

TT12 50%

Cole Pharma 10.5%

Behind C&N HOLDING are Ter Loonst BV and Arphius BV. It owns 51% of Phytomed SA, 50% of TT12 and 10.5% of Cole Pharma itself.

Directors

According to the 2025 annual accounts

Ter Loonst BV

Director · represented by Caroline Steensels

Also active at: Arphius, KDT Consulting, STUDIO PHARMA, IN2PHARMA

Arphius BV

Director · represented by Nico Swinnen

Also active at: Berkley Investments, XeniT Solutions, IN2PHARMA

Establishments

Establishment units

Physical locations of this company

Registered office

Terloonststraat 22

1910 Kampenhout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

Arphius same network

€ 155,701 gross margin · 2025

Ter Loonst same network

€ 1.5 million gross margin · 2025

TT 12 same network

€ 5,286 gross margin · 2025

IN2PHARMA same network

€ 2.4 million gross margin · 2025

PHC Group

€ 22,254 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0866.337.880

VAT number

BE 0866.337.880

Registered office

Terloonststraat 22, 1910 Kampenhout

Names & denominations

C&N HOLDING

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 July 2004

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

C&N HOLDING

Warning lights

Financials

What happened to C&N HOLDING?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions